The success of Sildenafil initially fueled a surge for the drug industry, but recent changes present a uncertain outlook for shareholders. Lower-cost competitors are reducing profits, and continued patent challenges https://antonsrlb067006.blogprodesign.com/62585709/sildenafil-and-big-pharma-a-risky-play